Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.08
-0.27 (-4.25%)
At close: Nov 16, 2026, 4:00 PM EST
6.19
+0.11 (1.81%)
After-hours: Nov 16, 2026, 7:33 PM EST

Cartesian Therapeutics Revenue

Cartesian Therapeutics had revenue of $1.03M in the twelve months ending September 30, 2026, down -6.05% year-over-year. In the year 2025, Cartesian Therapeutics had annual revenue of $2.80M, down -92.81%. That makes Cartesian Therapeutics the 43,607th largest company in the world by revenue and 6,093rd in the United States.

Revenue (ttm)
$1.03M
Revenue Growth
-6.05%
P/S Ratio
180.93
Revenue / Employee
$13,667
Employees
75
Market Cap
185.46M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.80M-36.12M-92.81%
Dec 31, 202438.91M12.91M49.64%
Dec 31, 202326.00M-84.77M-76.53%
Dec 31, 2022110.78M25.70M30.21%
Dec 31, 202185.08M68.48M412.60%
Dec 31, 202016.60M9.92M148.57%
Dec 31, 20196.68M5.77M639.42%
Dec 31, 2018903.00K696.00K336.23%
Dec 31, 2017207.00K-7.88M-97.44%
Dec 31, 20168.08M2.07M34.47%
Dec 31, 20156.01M2.97M97.73%
Dec 31, 20143.04M1.56M105.54%
Dec 31, 20131.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.